img

Global Nano Antibodies Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Nano Antibodies Market Research Report 2024

Nanoantibodies or "nAb" are single-domain VHH antibodies derived from camelidae (camels, llamas, alpacas, etc.). Compared with conventional monoclonal and polyclonal antibodies, nAbs have the following advantages

Small size (~15kd)
High affinity (frequently nanomolar range)
High specificity
Unsurpassed stability
According to Mr Accuracy reports’s new survey, global Nano Antibodies market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nano Antibodies market research.
Key companies engaged in the Nano Antibodies industry include Ablynx, PREGENE, Alphamab and PersonGen, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Nano Antibodies were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nano Antibodies market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nano Antibodies market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Ablynx
PREGENE
Alphamab
PersonGen
Segment by Type
Monovalent Nanobody
Multivalent and multispecific Nanobodies
Fusion Nanobody

Segment by Application


Disease detection in vitro
Non-invasive diagnosis in vivo
Tumor targeted therapy
Nervous system disease
Circulatory disease
Infectious disease
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Nano Antibodies report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nano Antibodies Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 Monovalent Nanobody
1.2.3 Multivalent and multispecific Nanobodies
1.2.4 Fusion Nanobody
1.3 Market by Application
1.3.1 Global Nano Antibodies Market Growth by Application: 2018 VS 2022 VS 2034
1.3.2 Disease detection in vitro
1.3.3 Non-invasive diagnosis in vivo
1.3.4 Tumor targeted therapy
1.3.5 Nervous system disease
1.3.6 Circulatory disease
1.3.7 Infectious disease
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nano Antibodies Market Perspective (2018-2034)
2.2 Nano Antibodies Growth Trends by Region
2.2.1 Global Nano Antibodies Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Nano Antibodies Historic Market Size by Region (2018-2024)
2.2.3 Nano Antibodies Forecasted Market Size by Region (2024-2034)
2.3 Nano Antibodies Market Dynamics
2.3.1 Nano Antibodies Industry Trends
2.3.2 Nano Antibodies Market Drivers
2.3.3 Nano Antibodies Market Challenges
2.3.4 Nano Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nano Antibodies Players by Revenue
3.1.1 Global Top Nano Antibodies Players by Revenue (2018-2024)
3.1.2 Global Nano Antibodies Revenue Market Share by Players (2018-2024)
3.2 Global Nano Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nano Antibodies Revenue
3.4 Global Nano Antibodies Market Concentration Ratio
3.4.1 Global Nano Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nano Antibodies Revenue in 2022
3.5 Nano Antibodies Key Players Head office and Area Served
3.6 Key Players Nano Antibodies Product Solution and Service
3.7 Date of Enter into Nano Antibodies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nano Antibodies Breakdown Data by Type
4.1 Global Nano Antibodies Historic Market Size by Type (2018-2024)
4.2 Global Nano Antibodies Forecasted Market Size by Type (2024-2034)
5 Nano Antibodies Breakdown Data by Application
5.1 Global Nano Antibodies Historic Market Size by Application (2018-2024)
5.2 Global Nano Antibodies Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Nano Antibodies Market Size (2018-2034)
6.2 North America Nano Antibodies Market Growth Rate by Country: 2018 VS 2022 VS 2034
6.3 North America Nano Antibodies Market Size by Country (2018-2024)
6.4 North America Nano Antibodies Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nano Antibodies Market Size (2018-2034)
7.2 Europe Nano Antibodies Market Growth Rate by Country: 2018 VS 2022 VS 2034
7.3 Europe Nano Antibodies Market Size by Country (2018-2024)
7.4 Europe Nano Antibodies Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nano Antibodies Market Size (2018-2034)
8.2 Asia-Pacific Nano Antibodies Market Growth Rate by Region: 2018 VS 2022 VS 2034
8.3 Asia-Pacific Nano Antibodies Market Size by Region (2018-2024)
8.4 Asia-Pacific Nano Antibodies Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nano Antibodies Market Size (2018-2034)
9.2 Latin America Nano Antibodies Market Growth Rate by Country: 2018 VS 2022 VS 2034
9.3 Latin America Nano Antibodies Market Size by Country (2018-2024)
9.4 Latin America Nano Antibodies Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nano Antibodies Market Size (2018-2034)
10.2 Middle East & Africa Nano Antibodies Market Growth Rate by Country: 2018 VS 2022 VS 2034
10.3 Middle East & Africa Nano Antibodies Market Size by Country (2018-2024)
10.4 Middle East & Africa Nano Antibodies Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ablynx
11.1.1 Ablynx Company Detail
11.1.2 Ablynx Business Overview
11.1.3 Ablynx Nano Antibodies Introduction
11.1.4 Ablynx Revenue in Nano Antibodies Business (2018-2024)
11.1.5 Ablynx Recent Development
11.2 PREGENE
11.2.1 PREGENE Company Detail
11.2.2 PREGENE Business Overview
11.2.3 PREGENE Nano Antibodies Introduction
11.2.4 PREGENE Revenue in Nano Antibodies Business (2018-2024)
11.2.5 PREGENE Recent Development
11.3 Alphamab
11.3.1 Alphamab Company Detail
11.3.2 Alphamab Business Overview
11.3.3 Alphamab Nano Antibodies Introduction
11.3.4 Alphamab Revenue in Nano Antibodies Business (2018-2024)
11.3.5 Alphamab Recent Development
11.4 PersonGen
11.4.1 PersonGen Company Detail
11.4.2 PersonGen Business Overview
11.4.3 PersonGen Nano Antibodies Introduction
11.4.4 PersonGen Revenue in Nano Antibodies Business (2018-2024)
11.4.5 PersonGen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Nano Antibodies Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2034
Table 2. Key Players of Monovalent Nanobody
Table 3. Key Players of Multivalent and multispecific Nanobodies
Table 4. Key Players of Fusion Nanobody
Table 5. Global Nano Antibodies Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2034
Table 6. Global Nano Antibodies Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 7. Global Nano Antibodies Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Nano Antibodies Market Share by Region (2018-2024)
Table 9. Global Nano Antibodies Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Nano Antibodies Market Share by Region (2024-2034)
Table 11. Nano Antibodies Market Trends
Table 12. Nano Antibodies Market Drivers
Table 13. Nano Antibodies Market Challenges
Table 14. Nano Antibodies Market Restraints
Table 15. Global Nano Antibodies Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Nano Antibodies Market Share by Players (2018-2024)
Table 17. Global Top Nano Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nano Antibodies as of 2022)
Table 18. Ranking of Global Top Nano Antibodies Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Nano Antibodies Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Nano Antibodies Product Solution and Service
Table 22. Date of Enter into Nano Antibodies Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Nano Antibodies Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Nano Antibodies Revenue Market Share by Type (2018-2024)
Table 26. Global Nano Antibodies Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Nano Antibodies Revenue Market Share by Type (2024-2034)
Table 28. Global Nano Antibodies Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Nano Antibodies Revenue Market Share by Application (2018-2024)
Table 30. Global Nano Antibodies Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Nano Antibodies Revenue Market Share by Application (2024-2034)
Table 32. North America Nano Antibodies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 33. North America Nano Antibodies Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Nano Antibodies Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Nano Antibodies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 36. Europe Nano Antibodies Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Nano Antibodies Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Nano Antibodies Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Asia-Pacific Nano Antibodies Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Nano Antibodies Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Nano Antibodies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 42. Latin America Nano Antibodies Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Nano Antibodies Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Nano Antibodies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2034
Table 45. Middle East & Africa Nano Antibodies Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Nano Antibodies Market Size by Country (2024-2034) & (US$ Million)
Table 47. Ablynx Company Detail
Table 48. Ablynx Business Overview
Table 49. Ablynx Nano Antibodies Product
Table 50. Ablynx Revenue in Nano Antibodies Business (2018-2024) & (US$ Million)
Table 51. Ablynx Recent Development
Table 52. PREGENE Company Detail
Table 53. PREGENE Business Overview
Table 54. PREGENE Nano Antibodies Product
Table 55. PREGENE Revenue in Nano Antibodies Business (2018-2024) & (US$ Million)
Table 56. PREGENE Recent Development
Table 57. Alphamab Company Detail
Table 58. Alphamab Business Overview
Table 59. Alphamab Nano Antibodies Product
Table 60. Alphamab Revenue in Nano Antibodies Business (2018-2024) & (US$ Million)
Table 61. Alphamab Recent Development
Table 62. PersonGen Company Detail
Table 63. PersonGen Business Overview
Table 64. PersonGen Nano Antibodies Product
Table 65. PersonGen Revenue in Nano Antibodies Business (2018-2024) & (US$ Million)
Table 66. PersonGen Recent Development
Table 67. Research Programs/Design for This Report
Table 68. Key Data Information from Secondary Sources
Table 69. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nano Antibodies Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Nano Antibodies Market Share by Type: 2022 VS 2034
Figure 3. Monovalent Nanobody Features
Figure 4. Multivalent and multispecific Nanobodies Features
Figure 5. Fusion Nanobody Features
Figure 6. Global Nano Antibodies Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Nano Antibodies Market Share by Application: 2022 VS 2034
Figure 8. Disease detection in vitro Case Studies
Figure 9. Non-invasive diagnosis in vivo Case Studies
Figure 10. Tumor targeted therapy Case Studies
Figure 11. Nervous system disease Case Studies
Figure 12. Circulatory disease Case Studies
Figure 13. Infectious disease Case Studies
Figure 14. Other Case Studies
Figure 15. Nano Antibodies Report Years Considered
Figure 16. Global Nano Antibodies Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 17. Global Nano Antibodies Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 18. Global Nano Antibodies Market Share by Region: 2022 VS 2034
Figure 19. Global Nano Antibodies Market Share by Players in 2022
Figure 20. Global Top Nano Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nano Antibodies as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Nano Antibodies Revenue in 2022
Figure 22. North America Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. North America Nano Antibodies Market Share by Country (2018-2034)
Figure 24. United States Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Canada Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Europe Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Europe Nano Antibodies Market Share by Country (2018-2034)
Figure 28. Germany Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. France Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. U.K. Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Italy Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Russia Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Nordic Countries Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Asia-Pacific Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Asia-Pacific Nano Antibodies Market Share by Region (2018-2034)
Figure 36. China Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Japan Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. South Korea Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Southeast Asia Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. India Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Australia Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Latin America Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Latin America Nano Antibodies Market Share by Country (2018-2034)
Figure 44. Mexico Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Brazil Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Middle East & Africa Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Middle East & Africa Nano Antibodies Market Share by Country (2018-2034)
Figure 48. Turkey Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 49. Saudi Arabia Nano Antibodies Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 50. Ablynx Revenue Growth Rate in Nano Antibodies Business (2018-2024)
Figure 51. PREGENE Revenue Growth Rate in Nano Antibodies Business (2018-2024)
Figure 52. Alphamab Revenue Growth Rate in Nano Antibodies Business (2018-2024)
Figure 53. PersonGen Revenue Growth Rate in Nano Antibodies Business (2018-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed